gattexrems.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | GATTEX |
| Description | GATTEX REMS (Risk Evaluation and Mitigation Home Prescribing Information Medication Guide GATTEX REMS ( R isk E valuation and M itigation S trategy) A REMS (Risk Evaluation and Mitigation Strategy) |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.73.185.30 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
gattexrems.com Valuation
|
US$2,027,707
Last updated: 2023-05-13 08:25:24
gattexrems.com has Semrush global rank of 5,219,839. gattexrems.com has an estimated worth of US$ 2,027,707, based on its estimated Ads revenue. gattexrems.com receives approximately 233,967 unique visitors each day. Its web server is located in United States, with IP address 52.73.185.30. According to SiteAdvisor, gattexrems.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,027,707 |
| Daily Ads Revenue | US$1,872 |
| Monthly Ads Revenue | US$56,152 |
| Yearly Ads Revenue | US$673,823 |
| Daily Unique Visitors | 15,598 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| gattexrems.com. | A | 7199 | IP: 52.73.185.30 |
| gattexrems.com. | NS | 86400 | NS Record: ns1.netnames.net. |
| gattexrems.com. | NS | 86400 | NS Record: ns2.netnames.net. |
| gattexrems.com. | NS | 86400 | NS Record: ns5.netnames.net. |
| gattexrems.com. | NS | 86400 | NS Record: ns6.netnames.net. |
HtmlToTextCheckTime:2023-05-13 08:25:24
| Home Prescribing Information Medication Guide GATTEX REMS ( R isk E valuation and M itigation S trategy) A REMS (Risk Evaluation and Mitigation Strategy) is a program required by the Food and Drug Administration (FDA) to manage known or potential serious risks associated with a drug product. The purpose of the GATTEX REMS is to inform healthcare providers, patients and caregivers about the following risks: Possible acceleration of neoplastic growth and Enhancement of colon polyp growth Gastrointestinal obstruction Biliary and pancreatic disorders Prescribers who intend to treat patients with GATTEX should review the educational materials and complete the Post-Training Knowledge Assessment Questions. Retraining is also available for prescribers who have not written a prescription for GATTEX within 12 months of completing assessment questions. Follow the Two Step Process Below For Initial Training Or Retraining: For Healthcare Providers Dear Healthcare Professional Letter Prescriber |
HTTP Headers
HTTP/1.1 200 OK Cache-Control: private Content-Length: 7420 Content-Type: text/html; charset=utf-8 Server: Microsoft-IIS/8.5 X-AspNetMvc-Version: 5.2 X-AspNet-Version: 4.0.30319 X-UA-Compatible: IE=edge,chrome=1 Date: Tue, 21 Dec 2021 01:34:23 GMT |
gattexrems.com Whois Information
Domain Name: GATTEXREMS.COM Registry Domain ID: 1704328774_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-02-23T06:20:19Z Creation Date: 2012-02-27T17:40:26Z Registry Expiry Date: 2022-02-27T17:40:26Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.NETNAMES.NET Name Server: NS2.NETNAMES.NET Name Server: NS5.NETNAMES.NET Name Server: NS6.NETNAMES.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T07:50:51Z <<< |